Gene · 6103
Papers1,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Identification of numerous novel disease-causing variants in patients with inherited retinal diseases, combining careful clinical-functional phenotyping with systematic, broad NGS panel-based genotyping. | Mol Vis | 2022 | 36284670 | PubTator, text mining | PubMed |
| Analysis of RPGR gene mutations in 41 Chinese families affected by X-linked inherited retinal dystrophy. | Front Genet | 2022 | 36276946 | PubTator, text mining | PubMed |
| Anatomical and functional correlates of cystic macular edema in retinitis pigmentosa. | PLoS One | 2022 | 36269735 | PubTator, text mining | PubMed |
| HBEGF-TNF induce a complex outer retinal pathology with photoreceptor cell extrusion in human organoids. | Nat Commun | 2022 | 36261438 | PubTator, text mining | PubMed |
| Using single molecule Molecular Inversion Probes as a cost-effective, high-throughput sequencing approach to target all genes and loci associated with macular diseases. | Hum Mutat | 2022 | 36259723 | PubTator, text mining | PubMed |
| Susceptibility of TNFAIP8, TNFAIP8L1, and TNFAIP2 Gene Polymorphisms on Cancer Risk: A Comprehensive Review and Meta-Analysis of Case-Control Studies. | Technol Cancer Res Treat | 2022 | 36254562 | PubTator, text mining | PubMed |
| Molecular pathology of Usher 1B patient-derived retinal organoids at single cell resolution. | Stem Cell Reports | 2022 | 36240775 | PubTator, text mining | PubMed |
| Role of IGF2BPs in head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36237306 | PubTator, text mining | PubMed |
| CRISPR/Cas9-A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects. | Int J Mol Sci | 2022 | 36232782 | PubTator, text mining | PubMed |
| SurviveAI: Long Term Survival Prediction of Cancer Patients Based on Somatic RNA-Seq Expression. | Cancer Inform | 2022 | 36225330 | PubTator, text mining | PubMed |
| LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway. | Gland Surg | 2022 | 36221286 | PubTator, text mining | PubMed |
| The Endoplasmic Reticulum ATP13A1 is Essential for MAVS-Mediated Antiviral Innate Immunity. | Adv Sci (Weinh) | 2022 | 36216581 | PubTator, text mining | PubMed |
| Utility of No-Charge Panel Genetic Testing for Inherited Retinal Diseases in a Real-World Clinical Setting. | J Vitreoretin Dis | 2022 | 36213299 | PubTator, text mining | PubMed |
| Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA-Virus Inhibitors. | Angew Chem Int Ed Engl | 2022 | 36208117 | PubTator, text mining | PubMed |
| AAV vectors: The Rubik's cube of human gene therapy. | Mol Ther | 2022 | 36203359 | PubTator, text mining | PubMed |
| Enhancement of effector functions of anti-CD20 monoclonal antibody by increased afucosylation in CHO cell line through cell culture medium optimization. | J Genet Eng Biotechnol | 2022 | 36194313 | PubTator, text mining | PubMed |
| A single helix repression domain is functional across diverse eukaryotes. | Proc Natl Acad Sci U S A | 2022 | 36191192 | PubTator, text mining | PubMed |
| Genomic characterization of a new phage BUCT541 against Klebsiella pneumoniae K1-ST23 and efficacy assessment in mouse and Galleria mellonella larvae. | Front Microbiol | 2022 | 36187954 | PubTator, text mining | PubMed |
| Microtubule modification defects underlie cilium degeneration in cell models of retinitis pigmentosa associated with pre-mRNA splicing factor mutations. | Front Genet | 2022 | 36176300 | PubTator, text mining | PubMed |
| Alternative ANKHD1 transcript promotes proliferation and inhibits migration in uterine corpus endometrial carcinoma. | NPJ Genom Med | 2022 | 36171217 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6103/papers?page=20